These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 33713976)
1. Recent advances in biological activities of rhodium complexes: Their applications in drug discovery research. Sohrabi M; Saeedi M; Larijani B; Mahdavi M Eur J Med Chem; 2021 Apr; 216():113308. PubMed ID: 33713976 [TBL] [Abstract][Full Text] [Related]
2. Group 9 organometallic compounds for therapeutic and bioanalytical applications. Ma DL; Chan DS; Leung CH Acc Chem Res; 2014 Dec; 47(12):3614-31. PubMed ID: 25369127 [TBL] [Abstract][Full Text] [Related]
3. Rhodium complexes as therapeutic agents. Ma DL; Wang M; Mao Z; Yang C; Ng CT; Leung CH Dalton Trans; 2016 Feb; 45(7):2762-71. PubMed ID: 26743935 [TBL] [Abstract][Full Text] [Related]
4. Antagonizing STAT3 dimerization with a rhodium(III) complex. Ma DL; Liu LJ; Leung KH; Chen YT; Zhong HJ; Chan DS; Wang HM; Leung CH Angew Chem Int Ed Engl; 2014 Aug; 53(35):9178-82. PubMed ID: 24889897 [TBL] [Abstract][Full Text] [Related]
10. Rh(iii)-Catalyzed diastereoselective transfer hydrogenation: an efficient entry to key intermediates of HIV protease inhibitors. Wang F; Zheng LS; Lang QW; Yin C; Wu T; Phansavath P; Chen GQ; Ratovelomanana-Vidal V; Zhang X Chem Commun (Camb); 2020 Mar; 56(21):3119-3122. PubMed ID: 32090223 [TBL] [Abstract][Full Text] [Related]
11. Versatile new C(3)-symmetric tripodal tetraphosphine ligands; structural flexibility to stabilize Cu(I) and Rh(I) species and tune their reactivity. Wassenaar J; Siegler MA; Spek AL; de Bruin B; Reek JN; van der Vlugt JI Inorg Chem; 2010 Jul; 49(14):6495-508. PubMed ID: 20552965 [TBL] [Abstract][Full Text] [Related]
12. Comparative solution equilibrium studies of antitumor ruthenium(η Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of C4 diphosphine ligands in rhodium catalysed methanol carbonylation under a syngas atmosphere: synthesis, structure, stability and reactivity of rhodium(I) carbonyl and rhodium(III) acetyl intermediates. Lamb G; Clarke M; Slawin AM; Williams B; Key L Dalton Trans; 2007 Dec; (47):5582-9. PubMed ID: 18043821 [TBL] [Abstract][Full Text] [Related]
14. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes. Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of new salicylaldehyde-2-picolinylhydrazone Schiff base compounds of Ru(II), Rh(III) and Ir(III) as in vitro antitumor, antibacterial and fluorescence imaging agents. Palepu NR; Nongbri SL; Premkumar JR; Verma AK; Bhattacharjee K; Joshi SR; Forbes S; Mozharivskyj Y; Thounaojam R; Aguan K; Kollipara MR J Biol Inorg Chem; 2015 Jun; 20(4):619-38. PubMed ID: 25712889 [TBL] [Abstract][Full Text] [Related]
16. Selective Aliphatic Carbon-Carbon Bond Activation by Rhodium Porphyrin Complexes. To CT; Chan KS Acc Chem Res; 2017 Jul; 50(7):1702-1711. PubMed ID: 28609611 [TBL] [Abstract][Full Text] [Related]
17. Rhodium(III) complexes derived from complexation of metal with azomethine linkage of chitosan biopolymer Schiff base ligand: Spectral, thermal, morphological and electrochemical studies. Vadivel T; Dhamodaran M; Kulathooran S; Kavitha S; Amirthaganesan K; Chandrasekaran S; Ilayaraja S; Senguttuvan S Carbohydr Res; 2020 Jan; 487():107878. PubMed ID: 31760235 [TBL] [Abstract][Full Text] [Related]